Presentation Spontaneous MI After NSTE ACS Managed Without Revascularization Presenter: Renato Lopes March 15, 2016
News Daily News Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data Todd Neale February 01, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2016 Shelley Wood February 01, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
Presentation Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS Presenter: Tobias Geisler September 18, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Daily News RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years July 30, 2015
News Daily News La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia Todd Neale July 13, 2015
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Daily News FDA Approval of Cangrelor Expands Antiplatelet Options for PCI Todd Neale June 29, 2015
News Daily News Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS June 04, 2015